Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Advanced Malignant Solid Tumors
Interventions: DRUG: neratinib|DRUG: vinorelbine
Sponsor: Puma Biotechnology, Inc.